Yifan Wang et al. showed that the expression of protease-activated receptor 1 (PAR1) was correlated with a poor prognosis of ER-negative breast cancer, in which PAR can regulate the YAP/TAZ axis to increase cell motility and cancer stem-like activity [156]. This evidence concerns the gene F2R and cancer.